Abstract
This report is about the molecular diagnostics market, including systems,
consumables and clinical lab services. These key medical products and services
use technologies that can detect single or multiple genomic, protein,
metabolomic or other ‘-omic' biomarkers.
The detailed study shows that molecular diagnostic companies are expecting
continued strong growth. Takeda Pacific' s report shows the major areas of this
dynamic market landscape. This report shows various views of this growing
multi-billion dollar market. The study sizes the market and projects the
5-year trend. The report charts the developments of more than 80 companies
involved in this dynamic industry.
This report discusses government regulatory initiatives to accelerate the
approvals of emerging molecular diagnostics by integrating biomarkers and
companion pharmacogenomic tests. Myriad, Veridex, Genomic Health, Agendia and
others are gaining traction detecting cancers. Roche' s Affymetrix-based tests
measure how patients respond to 30 or more currently marketed drugs. These
products enable the emerging field of personalized medicine. The passing of
the GINA law in the US might foster the growth of more molecular diagnostics,
clinical lab services and other related genetic testing services.
This study is full of interesting data and includes more than 43 figures and
tables. The tables provide data about technologies, companies, product
pipelines, partnerships and more. The study also has additional data such as
the global incidence and prevalence of major diseases. The report analyzes
partnering deals and includes several years of alliance and M&A data.
Thirty-eight selected companies are profiled, with details including contact
information, business and product overviews, alliances and patent or other
financial details.
This report would benefit people with job titles including CEO, VPs, Director
of Business Development, Research Directors, Entrepreneurs, Venture
Capitalists, Investment Planners, Research Scientists, Consultants or Industry
Analysts.
About Takeda Pacific
Consultants at Takeda Pacific developed this report. The company provides
business consulting that focuses on facilitating business development and
market research projects. The business projects may involve European, Japanese
and North American Life Science companies. Since it' s founding in late 1992,
TP has reviewed or analyzed thousands of Life Science and Technology firms for
its clients.
During the past twelve years, Takeda Pacific has produced over 70 industry
reports about emerging pharma, biotech, med-devices and technology companies
and markets. Takeda Pacific also offers follow-up consulting or custom
research consulting to assist in your business development, benchmarking, or
market assessment projects.
| 
View Cart
